We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
Cap. Flow
+$908M
Cap. Flow %
14.82%
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$85M
2
ABT icon
Abbott
ABT
+$72M
3
NVDA icon
NVIDIA
NVDA
+$60.9M
4
TER icon
Teradyne
TER
+$52.2M
5
LEGN icon
Legend Biotech
LEGN
+$50.2M

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$98.7M
2
TXN icon
Texas Instruments
TXN
+$95.4M
3
GPN icon
Global Payments
GPN
+$54.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$49.4M
5
KLAC icon
KLA
KLAC
+$49M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Technology 25.67%
3 Communication Services 8.98%
4 Financials 5.47%
5 Consumer Staples 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRVA icon
251
Privia Health
PRVA
$3.02B
$4.94M 0.08%
209,675
+76,925
+58% +$2.69M
REVHU
252
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$4.92M 0.08%
500,000
– –
RXDX
253
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$4.92M 0.08%
207,537
+4,855
+2% +$115K
LENZ
254
LENZ Therapeutics
LENZ
$165M
$4.92M 0.08%
42,862
-1,384
-3% -$205K
RVNC
255
DELISTED
Revance Therapeutics, Inc.
RVNC
$4.89M 0.08%
+175,359
New +$5M
AAQC
256
DELISTED
Accelerate Acquisition Corp
AAQC
$4.87M 0.08%
500,000
– –
CVII
257
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$4.86M 0.08%
500,000
– –
ELDN icon
258
Eledon Pharmaceuticals
ELDN
$266M
$4.83M 0.08%
781,376
-76,069
-9% -$532K
RDNT icon
259
RadNet
RDNT
$5.27B
$4.8M 0.08%
163,911
+105,791
+182% +$3.39M
VTRS icon
260
Viatris
VTRS
$20.6B
$4.7M 0.08%
346,500
– –
BRDG
261
DELISTED
Bridge Investment Group
BRDG
$4.68M 0.08%
+265,148
New +$4.57M
LEAP
262
DELISTED
Ribbit LEAP, Ltd.
LEAP
$4.68M 0.08%
462,722
– –
ATC
263
DELISTED
Atotech Limited
ATC
$4.67M 0.08%
193,302
+126,050
+187% +$3.03M
COCH icon
264
Envoy Medical
COCH
$52.7M
$4.61M 0.08%
475,000
– –
ULCC icon
265
Frontier Group Holdings
ULCC
$1.83B
$4.61M 0.08%
291,970
+1,520
+0.5% +$23.5K
IOVA icon
266
Iovance Biotherapeutics
IOVA
$1.94B
$4.58M 0.07%
+185,552
New +$4.37M
SRRK icon
267
Scholar Rock
SRRK
$5.74B
$4.5M 0.07%
136,359
– –
LOCL icon
268
Local Bounti
LOCL
$23.5M
$4.47M 0.07%
+34,615
New +$4.45M
QTEK
269
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$4.47M 0.07%
+450,000
New +$4.45M
RPID icon
270
Rapid Micro Biosystems
RPID
$105M
$4.46M 0.07%
+241,457
New +$4.99M
GRNA
271
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$4.45M 0.07%
+450,000
New +$4.41M
BCAB icon
272
BioAtla
BCAB
$5.53M
$4.44M 0.07%
+3,014
New +$5.87M
ALTI icon
273
AlTi Global
ALTI
$512M
$4.43M 0.07%
449,999
+399,999
+800% +$3.88M
OSI
274
DELISTED
Osiris Acquisition Corp.
OSI
$4.42M 0.07%
+450,000
New +$4.35M
SNPO
275
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$4.37M 0.07%
+262,142
New +$4.88M
9 10
11
12 13

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.

  • Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
  • Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
  • Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
  • Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
  • Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.

Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.